IL17A and diabetes mellitus: Most recently, it is reported that in vitro generated IL-17-producing T regulatory cells for BDC2.5 TCR transgenic CD4+ T regulatory cells (cultured with TGF-β and IL-6) were able to inhibit transfer of diabetes [60].